Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2007 Aug;78(8):825-31.
doi: 10.1136/jnnp.2006.106021. Epub 2007 Jan 12.

Carotid body autotransplantation in Parkinson disease: a clinical and positron emission tomography study

Adolfo Mínguez-Castellanos  1 , Francisco Escamilla-Sevilla, Gary R Hotton, Juan J Toledo-Aral, Angel Ortega-Moreno, Simón Méndez-Ferrer, José M Martín-Linares, Majed J Katati, Pablo Mir, Javier Villadiego, Miguel Meersmans, Miguel Pérez-García, David J Brooks, Ventura Arjona, José López-Barneo
Affiliations
Clinical Trial

Carotid body autotransplantation in Parkinson disease: a clinical and positron emission tomography study

Adolfo Mínguez-Castellanos et al. J Neurol Neurosurg Psychiatry. 2007 Aug.

Abstract

Background: Carotid body (CB) glomus cells are highly dopaminergic and express the glial cell line derived neurotrophic factor. The intrastriatal grafting of CB cell aggregates exerts neurotrophic actions on nigrostriatal neurons in animal models of Parkinson disease (PD).

Objective: We conducted a phase I-II clinical study to assess the feasibility, long term safety, clinical and neurochemical effects of intrastriatal CB autotransplantation in patients with PD.

Methods: Thirteen patients with advanced PD underwent bilateral stereotactic implantation of CB cell aggregates into the striatum. They were assessed before surgery and up to 1-3 years after surgery according to CAPIT (Core Assessment Programme for Intracerebral Transplantation) and CAPSIT-PD (Core Assessment Programme for Surgical Interventional Therapies in Parkinson's Disease) protocols. The primary outcome measure was the change in video blinded Unified Parkinson's Disease Rating Scale III score in the off-medication state. Seven patients had 18F-dopa positron emission tomography scans before and 1 year after transplantation.

Results: Clinical amelioration in the primary outcome measure was observed in 10 of 12 blindly analysed patients, which was maximal at 6-12 months after transplantation (5-74%). Overall, mean improvement at 6 months was 23%. In the long term (3 years), 3 of 6 patients still maintained improvement (15-48%). None of the patients developed off-period dyskinesias. The main predictive factors for motor improvement were the histological integrity of the CB and a milder disease severity. We observed a non-significant 5% increase in mean putaminal 18F-dopa uptake but there was an inverse relationship between clinical amelioration and annual decline in putaminal 18F-dopa uptake (r = -0.829; p = 0.042).

Conclusions: CB autotransplantation may induce clinical effects in patients with advanced PD which seem partly related to the biological properties of the implanted glomus cells.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None.

References

    1. Braak H, Del Tredici K, Rüb U.et al Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 200324197–211. - PubMed
    1. Lang A E, Lozano A M. Parkinson's disease: second of two parts. N Engl J Med 19983391130–1143. - PubMed
    1. Krack P, Batir A, Van Blercom N.et al Five‐year follow‐up of bilateral stimulation of the subthalamic nucleus in advanced Parkinsońs disease. N Engl J Med 20033491925–1934. - PubMed
    1. Dunnett S B, Bjorklund A. Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 1999399A32–A39. - PubMed
    1. Freed C R, Greene P E, Breeze R E.et al Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001344710–719. - PubMed

Publication types